Expana to change the monthly assessment schedule for some of its Plant-Based Protein EBP
February 16, 2025
Following a period of market feedback, Expana has decided to change the assessment schedule for some of its US-based Plant-Based Protein Expana Benchmark Prices (EBP) from Friday, March 28th, 2025, onwards.
The changes are as follows:
- The monthly US-based Plant-Based Protein EBP will be assessed on the last business day of every month at 16:00 US Eastern Standard Time.
The schedule change will bring the assessment in line with the region they are assessed in. Full details of our methodology, including the public holidays observed in the Americas, can be found in the Expana Assessment Methodology Guide available here.
A full list of the affected US Plant-Based Protein EBP is as follows:
Assessment Name |
Code |
Description |
Soy Protein Concentrate EXW North America |
SCA1 |
Soy protein; Concentrate; Protein content: Min. 65%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
Soy Protein Texturized Concentrate EXW North America |
SCA2 |
Soy protein; Texturized concentrate; Texturized protein content: Min. 65%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
Soy Protein Isolate EXW North America |
SIA1 |
Soy protein; Isolate; Protein content: 80-90%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
Pea Protein Concentrate EXW North America |
PCA1 |
Pea protein; Concentrate; Protein content: Min. 55%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
Pea Protein Texturized Concentrate EXW North America |
PCA2 |
Pea protein; Texturized concentrate; Texturized protein content: Min. 55%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
Pea Protein Isolate EXW North America |
PIA1 |
Pea protein; Isolate; Protein content: 80-85%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
This methodology change will come into effect on Friday, March 28th, 2025.
Please send any feedback about this proposal to [email protected] and clearly state which market note your comments relate to, and if comments are intended for publication by Expana.
Expana will acknowledge receipt of all comments by email.